Ceramide synthase 2

CERS2
Identifiers
AliasesCERS2, L3, LASS2, SP260, TMSG1, ceramide synthase 2
External IDsMGI: 1924143 HomoloGene: 39581 GeneCards: CERS2
RNA expression pattern
More reference expression data
Orthologs
SpeciesHumanMouse
Entrez

29956

76893

Ensembl

ENSG00000143418

ENSMUSG00000015714

UniProt

Q96G23

Q924Z4

RefSeq (mRNA)

NM_013384
NM_022075
NM_181746

NM_029789
NM_001320492

RefSeq (protein)

NP_071358
NP_859530

NP_001307421
NP_084065

Location (UCSC)Chr 1: 150.96 – 150.98 MbChr 3: 95.31 – 95.32 Mb
PubMed search[1][2]
Wikidata
View/Edit HumanView/Edit Mouse

Ceramide synthase 2, also known as LAG1 longevity assurance homolog 2 or Tumor metastasis-suppressor gene 1 protein is an enzyme that in humans is encoded by the CERS2 gene.

Ceramide synthase 2 is a ceramide synthase that catalyses the synthesis of very long acyl chain ceramides, including C20 and C26 ceramides. It is the most ubiquitously expressed of all CerS and has the broadest distribution in the human body.[3]

CerS2 was first identified in 2001.[4] It contains the conserved TLC domain and Hox-like domain common to almost all CerS.[5]

Distribution

CerS2 mRNA (TRH3) has been found in most tissues and it is strongly expressed in liver, intestine and brain.[6] CerS2 is much more widely distributed than Ceramide synthase 1 (CerS1) and is found in at least 12 tissues in the human body, with high expression in the kidney and liver, and moderate expression in the brain and other organs. In the mouse brain, CerS2 is mainly expressed white matter tracts, specifically in oligodendrocytes and Schwann cells.[5][7]

Function

Expression of CerS2 is transiently increased during periods of active myelination, suggesting that it is important for the synthesis of myelin sphingolipids.[7] The lack of CerS2, as shown in knockout mice, induces the autophagy and activation of the unfolded protein response (UPR).[5] These mice showed no decrease in overall ceramide level, but levels of sphinganine were elevated. They also developed severe liver disease, but there was no observable change in the kidneys.[8]

The CerS2 gene is compact in size and is located in a chromosomal region that is replicated early in the cell cycle.[5] CerS2 activity is regulated by sphingosine-1-phosphate (S1P) via two sphingosine-1-phosphate receptor-like residues on CerS2 that operate independently.[5]

Pathological Significance

CerS2 levels are significantly elevated in breast cancer tissue compared to normal tissue, along with increased levels of ceramide synthase 6 (CerS6).[5]

CerS2 was also implicated in the control of body weight. The administration of leptin to rats induced a decrease in CerS2 was observed in white adipose tissue.[5]

References

  1. ↑ "Human PubMed Reference:".
  2. ↑ "Mouse PubMed Reference:".
  3. ↑ Stiban J, Tidhar R, Futerman AH (2010). "Ceramide synthases: roles in cell physiology and signaling". Advances in Experimental Medicine and Biology. 688: 60–71. PMID 20919646. doi:10.1007/978-1-4419-6741-1_4.
  4. ↑ Pan H, Qin WX, Huo KK, et al. (September 2001). "Cloning, mapping, and characterization of a human homologue of the yeast longevity assurance gene LAG1". Genomics. 77 (1-2): 58–64. PMID 11543633. doi:10.1006/geno.2001.6614.
  5. 1 2 3 4 5 6 7 Levy M, Futerman AH (May 2010). "Mammalian ceramide synthases". IUBMB Life. 62 (5): 347–56. PMC 2858252 Freely accessible. PMID 20222015. doi:10.1002/iub.319.
  6. ↑ Riebeling C, Allegood JC, Wang E, Merrill AH Jr, Futerman AH (Oct 2003). "Two mammalian longevity assurance gene (LAG1) family members, trh1 and trh4, regulate dihydroceramide synthesis using different fatty acyl-CoA donors". J Biol Chem. 278 (44): 43452–9. PMID 12912983. doi:10.1074/jbc.M307104200.
  7. 1 2 Becker I, Wang-Eckhardt L, Yaghootfam A, Gieselmann V, Eckhardt M (February 2008). "Differential expression of (dihydro)ceramide synthases in mouse brain: oligodendrocyte-specific expression of CerS2/Lass2". Histochemistry and Cell Biology. 129 (2): 233–41. PMID 17901973. doi:10.1007/s00418-007-0344-0.
  8. ↑ Pewzner-Jung Y, Brenner O, Braun S, Laviad EL, Ben-Dor S, Feldmesser E, Horn-Saban S, Amann-Zalcenstein D, Raanan C, Berkutzki T, Erez-Roman R, Ben-David O, Levy M, Holzman D, Park H, Nyska A, Merrill AH, Futerman AH (April 2010). "A critical role for ceramide synthase 2 in liver homeostasis: II. insights into molecular changes leading to hepatopathy". J. Biol. Chem. 285 (14): 10911–23. PMC 2856297 Freely accessible. PMID 20110366. doi:10.1074/jbc.M109.077610.

Further reading

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.